TISSUE THERAPIES
TISSUE THERAPIES operates in Diversified Metals & Mining.
TISSUE THERAPIES - Asset Resilience Ratio
TISSUE THERAPIES (1TT) has an Asset Resilience Ratio of 27.90% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2022)
This chart shows how TISSUE THERAPIES's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down TISSUE THERAPIES's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.64 Million | 27.9% |
| Total Liquid Assets | €1.64 Million | 27.90% |
Asset Resilience Insights
- Very High Liquidity: TISSUE THERAPIES maintains exceptional liquid asset reserves at 27.90% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
TISSUE THERAPIES Industry Peers by Asset Resilience Ratio
Compare TISSUE THERAPIES's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
LINDT & SPRUENGLI N - Dusseldorf Stock Exchang
DU:LSPN |
Other | 0.00% |
|
PRICELINE.COM
BE:PCE1 |
Other | 0.00% |
|
PRICELINE GROUP (PCE1.SG)
STU:PCE1 |
Other | 0.00% |
|
MURPHY USA
BE:1MU |
Other | 0.03% |
|
DIOS EXPLORATIONS
BE:BFM |
Other | 3.47% |
|
CHINA YUCHAI INTL (CYD.SG)
STU:CYD |
Other | 1.46% |
|
MEDIGENE N (MDG1.SG)
STU:MDG1 |
Other | 21.48% |
Annual Asset Resilience Ratio for TISSUE THERAPIES (2021–2022)
The table below shows the annual Asset Resilience Ratio data for TISSUE THERAPIES.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | 27.90% | €1.64 Million | €5.88 Million | +9.66pp |
| 2021-12-31 | 18.24% | €1.26 Million | €6.89 Million | -- |